Technologies for Diabetes Management - Forecasts, Players & Opportunities - Market for Artificial Pancreas Technologies will Exceed $6.5 Billion by 2027 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Technologies for Diabetes Management 2017-2027: Forecasts, Players, Opportunities" report to their offering.

This report covers mature, growing and emerging fields in diabetes technology, researched through primary interviews with companies, physicians and diabetic individuals to establish how the technological roadmap for diabetes management will develop over the next decade.

Historically glucose levels have been monitored using disposable biosensors, whereby a drop of blood is placed on to a sensor and an associated reader provides the result. While the glucose test strip industry produces billions of single use sensors a year, cuts to medical budgets are driving profitability down. Current invasive methods of glucose monitoring result in low patient compliance, leading to poor glucose control and the associated long term health implications.

These factors have led both start-ups and established players in the field to develop novel glucose sensing platforms based on alternative sampling sites and detection methods. Whilst many of these technologies will not be able to precisely replicate the accuracy of blood glucose measurements, some are making progress towards this goal and are achieving regulatory approval to commercialize products in to this emerging market.

Advancements in diabetes care are not limited to glucose monitoring, novel insulin delivery platforms provide another area of growth for the industry, with wearable insulin pumps now widely available. Such devices contain a range of sensors to that enable the safe and controlled delivery of insulin to a patient. Progression in both glucose monitoring and insulin delivery technologies are enabling the delivery of a previously conceptual artificial pancreas system, able to deliver controlled insulin doses, based on sensor outputs to optimize glucose levels. The market for these fully automated diabetes management systems is expected to reach $6.5 billion by 2027.

Companies Mentioned

  • Companion Medical
  • Dexcom
  • Dropsens
  • Emperra
  • GSI
  • GSK Medical
  • Glysens
  • Google-Verily
  • Medtronic
  • Nanoflex
  • PKVitality
  • Sensoria

Key Topics Covered:

1. EXECUTIVE SUMMARY

2. INTRODUCTION TO DIABETES

3. MARKET FORECASTS

4. SENSORS FOR GLUCOSE MONITORING

5. BEYOND BLOOD GLUCOSE MEASUREMENTS

6. SENSORS FOR KETONE MONITORING

7. SENSORS FOR INSULIN PENS

8. INSULIN PUMPS: TOWARDS AN ARTIFICIAL PANCREAS

9. SENSORS FOR SIDE EFFECTS

10. SENSORS FOR EARLY DIAGNOSIS

11. REGULATION AND AVAILABILITY OF DIABETES MEDICAL DEVICES

12. COMPANY PROFILE

For more information about this report visit http://www.researchandmarkets.com/research/c6fsm7/technologies_for

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Endocrinology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Endocrinology